| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/15/2004 | EP1485493A1 Novel method for the production of hybrid maize seeds |
| 12/15/2004 | EP1485492A2 Gntiii (udp-n-acetylglucosamine:beta-d mannoside beta(1,4)-n-acetylglucosaminyltransferase iii) expression in plants |
| 12/15/2004 | EP1485490A2 Yield-related polynucleotides and polypeptides in plants |
| 12/15/2004 | EP1485489A2 Dna sequences of major secreted proteins from the ciliate tetrahymena and use thereof |
| 12/15/2004 | EP1485488A2 Recombinant negative strand virus rna expression systems and vaccines |
| 12/15/2004 | EP1485486A2 Optimizing glycan processing in plants |
| 12/15/2004 | EP1485485A1 Transdifferentiation of cells and tissues |
| 12/15/2004 | EP1485484A2 Antigen fragments for the diagnosis of toxoplasma gondii |
| 12/15/2004 | EP1485483A1 Proteolysis resistant active vegf |
| 12/15/2004 | EP1485482A1 Inhibition of the beta3 subunit of l-type ca 2+ channels |
| 12/15/2004 | EP1485481A2 Fluorescent protein from aequorea coerulescens and uses thereof |
| 12/15/2004 | EP1485480A2 Cd40 splice variants, method of detection thereof, compositions comprising said variant(s) or nucleic acid encoding the same and use thereof |
| 12/15/2004 | EP1485478A1 Method of repressing flowering in a plant |
| 12/15/2004 | EP1485477A2 Novel type-1 cytokine receptor glm-r |
| 12/15/2004 | EP1485476A2 Dimeric tf antagonist |
| 12/15/2004 | EP1485469A2 Virus like particle from papillomavirus and their use in vaccine |
| 12/15/2004 | EP1485468A2 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 12/15/2004 | EP1485467A2 Recombinant expression vectors for functional na sb v /sb 1.9 sodium channels |
| 12/15/2004 | EP1485466A2 Methods for treating diseases or conditions with peptide constructs |
| 12/15/2004 | EP1485461A2 Protein biomarkers that distinguish prostate cancer from non-malignant cells |
| 12/15/2004 | EP1485413A2 Biologically active complex |
| 12/15/2004 | EP1485412A1 Repressor of skeletal muscle differentiation, nucleic acids coding therefor and the use thereof in diagnosis and therapy |
| 12/15/2004 | EP1485411A2 Arrays of cytosolic accessory proteins immobilized on a surface and pertinent methods |
| 12/15/2004 | EP1485410A1 Diagnostic and therapeutic use of human maguin proteins and nucleic acids for neurodegenerative diseases |
| 12/15/2004 | EP1485409A1 Compositions isolated from bovine mammary gland and methods for their use |
| 12/15/2004 | EP1485408A2 Mutagenesis of aspergillus fungi and genes essential for growth |
| 12/15/2004 | EP1485407A1 A mutated immunoglobulin-binding protein |
| 12/15/2004 | EP1485406A2 Highly homogeneous molecular markers for electrophoresis |
| 12/15/2004 | EP1485405A2 Melanin-concentrating hormone analogs |
| 12/15/2004 | EP1485401A1 Trpm-2 antisense therapy using an oligonucleotide having 2'-o-(-2-methoxyl)ethyl modifications |
| 12/15/2004 | EP1485398A2 Methods of screening for compounds that modulate hormone receptor activity |
| 12/15/2004 | EP1485139A1 Biomatrix and method for producing the same |
| 12/15/2004 | EP1485129A2 Nanostructures containing pilin protein |
| 12/15/2004 | EP1485128A2 Nanostructures containing antibody assembly units |
| 12/15/2004 | EP1485124A2 Method of inducing an enhanced immune response against hiv |
| 12/15/2004 | EP1485123A2 Method of inducing an enhanced immune response against hiv |
| 12/15/2004 | EP1485119A1 Enhancing the availability of minerals by using biologically active peptides |
| 12/15/2004 | EP1485108A2 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 12/15/2004 | EP1485075A2 Mhc-peptide complex binding ligands |
| 12/15/2004 | EP1484977A2 Compositions and methods for treating mdma-induced toxicity |
| 12/15/2004 | EP1421176A4 Nucleic acids and encoded polypeptides associated with bipolar disorder |
| 12/15/2004 | EP1414307A4 Method of enhancing the extraction of proteinase inhibitors |
| 12/15/2004 | EP1404845B1 Use of the cd24 marker gene for the selection of keratinocyte stem cells transformed by exogenous sequences |
| 12/15/2004 | EP1307562B1 Nucleotide sequences which code for the lysr3 gene |
| 12/15/2004 | EP1263779B1 Self antigen vaccines for treating b cell lymphomas and other cancers |
| 12/15/2004 | EP1224221B1 Transcription factor-selective nuclear transport receptors required for immune response activation |
| 12/15/2004 | EP1221964A4 Antigenic modification of polypeptides |
| 12/15/2004 | EP1212358B1 Synthetic papillomavirus genes optimized for expression in human cells |
| 12/15/2004 | EP1121448B1 EXPRESSION AND SECRETION OF icIL-1 RECEPTOR ANTAGONIST TYPE II |
| 12/15/2004 | EP1109931A4 METHOD FOR STUDYING PROTEIN INTERACTIONS $i(IN VIVO) |
| 12/15/2004 | EP1073461B1 Viral chimeras comprised of caev and hiv-1 genetic elements |
| 12/15/2004 | EP1068309B1 Enterotoxin-deficient bacillus |
| 12/15/2004 | EP1017832B1 Microspore-specific promoter and method for obtaining hybrid plants |
| 12/15/2004 | EP0988391B1 Recombinant adenoviral vectors comprising a splicing sequence |
| 12/15/2004 | EP0929691B1 Methods and compositions for identifying receptor effectors |
| 12/15/2004 | EP0863204B1 Human cyclin i and gene encoding the same |
| 12/15/2004 | EP0850310B1 Circular dna molecule with conditional origin of replication, method for preparing same and use thereof in gene therapy |
| 12/15/2004 | EP0773996B1 INTERRUPTION OF BINDING OF MDM2 AND p53 PROTEIN AND THERAPEUTIC APPLICATION THEREOF |
| 12/15/2004 | EP0638088B1 Hybrid human/porcine factor viii |
| 12/15/2004 | CN1555417A Paramyxovirus vector for gene transfer to the cardiovascular system |
| 12/15/2004 | CN1555415A Synthetic HCV envelope proteins and their use for vaccination |
| 12/15/2004 | CN1555414A Plant-derived resistance gene |
| 12/15/2004 | CN1555393A Keratin-based products and methods for their production |
| 12/15/2004 | CN1555384A Process for obtaining growth factor (tgf-beta and igf-1), lactoperoxidase and immunoglobulins preparations from milk products having low mutual cross-contamination |
| 12/15/2004 | CN1555383A Novel peptide, novel adsorbent, adsorption unit and adsorption method |
| 12/15/2004 | CN1555272A Compositions and methods for modulation of immune responses |
| 12/15/2004 | CN1555268A Therapeutic agents comprising pro-apoptotic proteins |
| 12/15/2004 | CN1555254A 免疫原性脂质体组合物 Immunogenic liposome composition |
| 12/15/2004 | CN1554764A Recombinant mva virus, and the use thereof |
| 12/15/2004 | CN1554665A Production process and use of epidermal cell colyone |
| 12/15/2004 | CN1554664A Compounds and methods for diagnosis of tuberculosis |
| 12/15/2004 | CN1554444A Endothelial cell proliferation inhibitor and method of use |
| 12/15/2004 | CN1180087C Expression of human interleukin-12 in craze noctuid and its purifying process |
| 12/15/2004 | CN1180084C Nucleic acid frament, recombniant vector containing same and method of promoting expression of structural gene by using same |
| 12/15/2004 | CN1180083C Cytochrome C and its gene |
| 12/15/2004 | CN1179976C Method for producing blood coagulation factor VIII host cell |
| 12/15/2004 | CN1179975C Scorpion peptide for treating arrhythmia and its preparing process and application |
| 12/15/2004 | CN1179974C Reverse-corelation-resisting signal transfer gene of plant and protein coded thereof |
| 12/15/2004 | CN1179973C HBV core antigen particles with multiple immunogenic components attached via peptide ligands |
| 12/14/2004 | US6831170 Fibroblast growth factor receptor activating gene I and related compositions and methods |
| 12/14/2004 | US6831169 Hepatitis C virus vaccine |
| 12/14/2004 | US6831166 Derivatized oligonucleotides having improved uptake and other properties |
| 12/14/2004 | US6831165 Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation |
| 12/14/2004 | US6831162 Protein/polypeptide-k obtained from Momordica charantia and a process for the extraction thereof |
| 12/14/2004 | US6831161 For chromatography; genetic engineering; albumin-binding protein |
| 12/14/2004 | US6831159 Method for purifying factor VIII/vWF company by cation-exchange chromatography |
| 12/14/2004 | US6831158 Granulocyte colony stimulating factor (g-csf) activity; polypeptide with an introduced and removed lysine residue conjugated to polyethylene glycol moieties; treatment of neutropenia or leukopenia |
| 12/14/2004 | US6831157 Process for the purification of serum albumin |
| 12/14/2004 | US6831156 Nuclear protein for use in the prevention and treatment of cell proliferation disorders |
| 12/14/2004 | US6831155 Polypeptide for use in the diagnosis and treatment of cancer |
| 12/14/2004 | US6831154 For drug screening/diagnosis/therapy/prevention; fusion proteins |
| 12/14/2004 | US6831153 Nucleotide sequences for use in the diagnosis and treatment of psychological disorders |
| 12/14/2004 | US6831152 Colon specific genes and proteins |
| 12/14/2004 | US6831151 Mast cell-specific signal transducing molecules and cDNAs thereof |
| 12/14/2004 | US6831070 Delivery of therapeutic gene products by intestinal cell expression |
| 12/14/2004 | US6831066 Amyloid precursor proteins with improved bioavailability; for treament of Alzheimer's disease |
| 12/14/2004 | US6831065 Anti-inflammatory compounds and uses thereof |
| 12/14/2004 | US6831064 Enhancing clearance of fluid and urinary waste into abdominal cavity; prolonging dialysis free intervals |
| 12/14/2004 | US6831063 Bridging Integrator-2(Bin2) nucleic acid molecules and proteins and uses therefor |
| 12/14/2004 | US6831062 Bacillus thuringiensis toxins with improved activity |